LT4313114T - Kombinuotas smegenų traumos gydymas - Google Patents

Kombinuotas smegenų traumos gydymas

Info

Publication number
LT4313114T
LT4313114T LTEPPCT/EP2022/057881T LTEP2022057881T LT4313114T LT 4313114 T LT4313114 T LT 4313114T LT EP2022057881 T LTEP2022057881 T LT EP2022057881T LT 4313114 T LT4313114 T LT 4313114T
Authority
LT
Lithuania
Prior art keywords
brain injury
combined treatment
treatment
combined
brain
Prior art date
Application number
LTEPPCT/EP2022/057881T
Other languages
English (en)
Inventor
Bruno Pietro Imbimbo
Gino Villetti
Fabrizio Facchinetti
Elisa LANDUCCI
Dalila MANGO
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of LT4313114T publication Critical patent/LT4313114T/lt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/185—Nerve growth factor [NGF]; Brain derived neurotrophic factor [BDNF]; Ciliary neurotrophic factor [CNTF]; Glial derived neurotrophic factor [GDNF]; Neurotrophins, e.g. NT-3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
    • A61F2007/0001—Body part
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
    • A61F2007/0001—Body part
    • A61F2007/0002—Head or parts thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Psychology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Otolaryngology (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
LTEPPCT/EP2022/057881T 2021-03-25 2022-03-25 Kombinuotas smegenų traumos gydymas LT4313114T (lt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP21165013 2021-03-25
PCT/EP2022/057881 WO2022200550A1 (en) 2021-03-25 2022-03-25 Combined treatment of brain injury

Publications (1)

Publication Number Publication Date
LT4313114T true LT4313114T (lt) 2025-11-25

Family

ID=75252298

Family Applications (1)

Application Number Title Priority Date Filing Date
LTEPPCT/EP2022/057881T LT4313114T (lt) 2021-03-25 2022-03-25 Kombinuotas smegenų traumos gydymas

Country Status (17)

Country Link
US (1) US20240165203A1 (lt)
EP (1) EP4313114B1 (lt)
JP (1) JP2024511613A (lt)
KR (1) KR20230160876A (lt)
CN (1) CN117062617A (lt)
AU (1) AU2022242765A1 (lt)
BR (1) BR112023019289A2 (lt)
CA (1) CA3212603A1 (lt)
DK (1) DK4313114T3 (lt)
FI (1) FI4313114T3 (lt)
LT (1) LT4313114T (lt)
MA (1) MA63937B1 (lt)
MX (1) MX2023011055A (lt)
PT (1) PT4313114T (lt)
RS (1) RS67383B1 (lt)
SM (1) SMT202500404T1 (lt)
WO (1) WO2022200550A1 (lt)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITRM20060367A1 (it) 2006-07-13 2008-01-14 Lay Line Genomics Spa Muteine del hngf usi terapeutici e composizioni farmaceutiche
CN103340713A (zh) * 2013-07-25 2013-10-09 重庆医科大学附属儿童医院 经直肠亚低温治疗装置
CN104288896B (zh) * 2014-06-25 2017-11-14 首都医科大学 一种颅脑灌注降温便携箱
US20180086805A1 (en) * 2016-05-20 2018-03-29 Chiesi Farmaceutici S.P.A. proNGF mutants and uses thereof for the preparation of NGF mutants
IT201600112420A1 (it) 2016-11-08 2018-05-08 Univ Cattolica Del Sacro Cuore Nuova formulazione per via intranasale

Also Published As

Publication number Publication date
CA3212603A1 (en) 2022-09-29
EP4313114B1 (en) 2025-09-17
DK4313114T3 (da) 2025-10-20
AU2022242765A1 (en) 2023-11-09
RS67383B1 (sr) 2025-11-28
JP2024511613A (ja) 2024-03-14
KR20230160876A (ko) 2023-11-24
WO2022200550A1 (en) 2022-09-29
FI4313114T3 (fi) 2025-11-10
EP4313114A1 (en) 2024-02-07
SMT202500404T1 (it) 2025-11-10
MX2023011055A (es) 2023-09-28
US20240165203A1 (en) 2024-05-23
PT4313114T (pt) 2025-11-25
MA63937B1 (fr) 2025-10-31
BR112023019289A2 (pt) 2024-01-30
CN117062617A (zh) 2023-11-14

Similar Documents

Publication Publication Date Title
GB201902419D0 (en) Treatment of kidney injury
CA227901S (en) Skin treatment equipment
IL304628A (en) Treatment of skin disorders
GB2605422B (en) Treatment of the central nervous system
IL282361A (en) Treatment for neurological diseases
CA3259999A1 (en) METHODS OF TREATING A BRAIN INJURY
PT4313114T (pt) Tratamento combinado de lesão cerebral
GB202102247D0 (en) Treatment of brain injuries
GB202114129D0 (en) Treatment of traumatic brain injury
GB202107701D0 (en) Treatment of traumatic brain injury
GB202105648D0 (en) Treatment of traumatic brain injury
GB202006727D0 (en) Treatment of traumatic brain injury
GB202104282D0 (en) Skin treatment apparatus
GB202102257D0 (en) Treatment of shells
GB202100566D0 (en) Treatment of brain damage
GB202001353D0 (en) Treatment of skin conditions
CA3266616A1 (en) TREATMENT OF MILD TRAUMATIC BRAIN INJURY
GB202116774D0 (en) Treatment of pain
GB202118007D0 (en) Methods of treatment
GB202118011D0 (en) Methods of treatment
GB202118006D0 (en) Methods of treatment
GB202104753D0 (en) Treatment of ophthalmological conditions
GB202108245D0 (en) Methods of treatment
GB202108242D0 (en) Methods of treatment
HK40073443A (en) Treatment of brain ischemia-reperfusion injury